OTCM
RAYT
Market cap0kUSD
Nov 15, Last price
0.00USD
Name
Rayont Inc
Chart & Performance
P/E
0.00
P/S
0.00
EPS
0.00
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
3m
+1,421.11%
Net income
245k
P
CFO
-169k
L+73.36%
Profile
Rayont Inc., through its subsidiary, THF Holdings Pty Ltd., operates as a cancer treatment and medical device company. The company was formerly known as Velt International Group Inc. Rayont Inc. was founded in 2011 and is based in Southport, Australia.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2022‑06 | 2020‑09 | 2019‑09 | 2018‑09 | 2017‑09 | 2016‑09 | 2015‑09 | |
| Income | |||||||
Revenues | 2,839 | ||||||
Cost of revenue | 1,457 | ||||||
Unusual Expense (Income) | |||||||
NOPBT | 1,383 | ||||||
NOPBT Margin | 48.69% | ||||||
Operating Taxes | 24 | ||||||
Tax Rate | 1.76% | ||||||
NOPAT | 1,358 | ||||||
Net income | 245 | ||||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | 108 | ||||||
BB yield | |||||||
| Debt | |||||||
Debt current | 2,605 | ||||||
Long-term debt | 5,776 | ||||||
Deferred revenue | |||||||
Other long-term liabilities | |||||||
Net debt | 8,195 | ||||||
| Cash flow | |||||||
Cash from operating activities | (169) | ||||||
CAPEX | (3,380) | ||||||
Cash from investing activities | (5,229) | ||||||
Cash from financing activities | 5,335 | ||||||
FCF | |||||||
| Balance | |||||||
Cash | 186 | ||||||
Long term investments | |||||||
Excess cash | 44 | ||||||
Stockholders' equity | (3,846) | ||||||
Invested Capital | 16,777 | ||||||
ROIC | 8.10% | ||||||
ROCE | 10.69% | ||||||
| EV | |||||||
Common stock shares outstanding | 47,896 | ||||||
Price | |||||||
Market cap | |||||||
EV | |||||||
EBITDA | 1,868 | ||||||
EV/EBITDA | |||||||
Interest | 615 | ||||||
Interest/NOPBT | 44.51% | ||||||